Efficacy and Safety of Albumin-Bound Paclitaxel Compared to Docetaxel as Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer

BACKGROUND: Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as neoadjuvant chemotherapy (NAC) for breast cancer remains controversial. We conducted a retrospective study to compare the efficacy and safety of nab-paclitaxel with those of docetaxel as neoadjuvant regimens for HER2-negative brea...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Zhi-Dong, Song, Hong-Ming, Niu, Zhao-He, Nie, Gang, Zheng, Shuai, Xu, Ying-Ying, Gong, Wei, Wang, Hai-Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787090/
https://www.ncbi.nlm.nih.gov/pubmed/35087749
http://dx.doi.org/10.3389/fonc.2021.760655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787090/
https://www.ncbi.nlm.nih.gov/pubmed/35087749
http://dx.doi.org/10.3389/fonc.2021.760655

Ejemplares similares